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A B S T R A C T   
Candida glabrata (C. glabrata) cell wall proteins play a role in virulence and in initial host immune recognition 
and responses. We isolated and characterized C. glabrata cell wall proteases from a clinical hospital C. glabrata T- 
1638 blood isolate and estimated the enzymatic activities and their ability to degrade gelatin and processing 
proMMP-8 and assess the regulation of these proteases with salt treatment, mercaptoethanol and fermented 
lingonberry juice from Vaccinium vitis idaea L. The cell wall proteases were enzymatically released from the cell 
wall and beta- 1,3- bonded proteases were fractioned into 10–50 kDa and >50 kDa fractions with anionic DEAE- 
sepharose ion-exchange chromatography and gel filtration. Proteins were monitored and analyzed with MDPF- 
zymography, and five gelatinolytic bands were cut out from a parallel silver-stained gel for the LC- MS/MS 
analysis. The proteases lacked a signal sequence, indicating that they are moonlighting proteases. Human 
proMMP-8 activation assays were performed with both fractions and verified by western-immunoblot using 
aMMP-8 specific antibody. Inhibition of proMMP-8 conversion to the lower molecular active enzyme species 
were demonstrated with fermented lingonberry juice. The results indicate that moonlighting proteases may play 
a role in the virulence of C. glabrata.   
1. Introduction 
Traditionally C. glabrata cell wall proteins are classified into GPI- 
and- PIR-proteins [1,2]. C. glabrata has not been shown to secrete pro-
teases, such as SAPs (secreted aspartic proteases) found from C. albicans, 
but certain studies show moonlighting proteins in the cell wall of 
C. albicans [3] and C. glabrata [4,5]. These intracellular proteins are 
secreted by a non-classical pathway in extracellular vesicles (ECVs) and 
are found in several microbial species attached to the cell wall [6–8]. 
The concept of intracellular proteins having an extracellular function 
has given an insight into protein molecules containing multiple func-
tions compared to what is traditionally shown [9]. Studies with 
Saccharomyces cerevisiae also show cell wall proteins found both in the 
cytosol and fungal cell wall [10]. C. glabrata cell wall proteins are in the 
first contact line with the host and eventually can attribute to the 
virulence of the organism and host immune responses. 
Proteases of microbial species e.g. periodontopathogenic bacteria 
Porphyromonas gingivalis and Treponema denticola have been shown the 
ability to degrade collagen fragments and activate latent host proMMP-1 
and pro-MMP-8 [11], and Treponema denticola chymotrypsin-like pro-
teinase has the ability to convert proMMP-8 and -9 into their active 
forms [12]. Pseudomonas aeruginosa elastase, Vibrio cholera proteinase 
and thermolysin can activate proMMP-1, proMMP-8 and proMMP-9 
[13], and Tannerella forsythia chymotrypsin-like serine protease mem-
brane bound enzyme degrades gelatin and type-I collagen [14]. Addi-
tionally, a Candida albicans cytoplasmic metalloprotease could 
completely degrade type I collagen and fibronectin, and partially 
degrade type IV collagen and laminin [15]. Several candidal species 
have been shown to possess cell wall associated/proteases secreted into 
the culture medium able to degrade or modify human derived basement 
membrane and extracellular proteins: laminin-332, fibronectin, 
E− cadherin, tissue inhibitor of metalloprotease-1 (TIMP-1) and 
proMMP-9 [16–20]. 
To this background we isolated C. glabrata cell wall proteases to 
determine and characterize their activities. 
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2. Results 
Fig. 1 Shows the effect of salt and 1.5 mM mercaptoethanol (ME)- 
treatments on the >50 kDa candidal fractions. 
The effects of ME treatment of the fractions are shown in Fig. 2. 
The bands showing gelatinolytic activity were cut out of the silver 
stained gel (Fig. 3a and 3b.). Distinct gelatinolytic activity bands were 
detected within 15.7 kDa–85.9 kDa range and these were identified 
using the Uniprot C. glabrata protein database. We identified five pro-
teases from the >50 kDa fraction without a traditional signal peptide: 
glucose- 6- phosphate isomerase (GPI) Q6FRW1 (61.3 kDa, coverage 
41.98%, score 41.71) (Fig. 3b band 4); glutamate dehydrogenase (GDH) 
Q6FWH3 (49.7 kDa, coverage 31.96%, score 65.03) (Fig. 3a band 2 and 
Fig. 3b band 3); 5-methyltetrahydropteroyltriglutamate - homocysteine 
methyltransferase (Met6), Q6FQM7 (85.9 kDa, coverage 31.29%, score 
24.97) (Fig. 3a band 1); transaldolase Q6FXG5 (36.7 kDa, coverage 
30.84%, score 46.95) (Fig. 3b band 5); phosphoglycerate kinase (PGK) 
Q6FKY1 (44.6 kDa, coverage 42.79%, score 6.61) (Fig. 3a band 3). 
Both the 10–50 kDa and especially the >50 kDa proteases frag-
mented the 70–75 kDa latent full-size human proMMP-8 into it’ s 30, 40, 
55 kDa lower molecular weight active species (Fig. 4a.). This proMMP-8 
fragmentation by candidal proteases could be inhibited by the fer-
mented lingonberry juice in the >50 kDa isolated candidal enzyme 
fraction (Fig. 4b.). The 10–50 kDa fraction data is not shown. 
3. Discussion 
Our results indicate, that C. glabrata possesses moonlighting pro-
teases in the cell wall. Several moonlighting proteases have been iden-
tified from C. glabrata [21]. These findings corroborate with our results. 
Some findings indicate cell wall proteins of C. albicans having properties 
affecting virulence in challenged environments, such as starvation and 
temperature upshift [22]. This may be the case also in C. glabrata viru-
lence. Glucose utilization is crucial for microbial growth and survival, e. 
g. the proper function of GDH (glutamate dehydrogenase) in Staphylo-
coccus aureus gives it enhanced ability to use glutamate as an energy 
source in abscesses etc. with limited glucose availability [23]. 
The inactivation of the >50 kDa proteases with mercaptoethanol 
showed, that there are intra/intermolecular disulphide bridges crucial 
for the gelatinolytic activity. The salt treatment of the fraction indicates 
some ionic bond-related activation of the gelatinolysis. 
Inactivation of the 10–50 kDa and >50 kDa fractions enzymatic 
activity with fermented lingonberry juice presents a potential ther-
apeutical agent against C. glabrata virulence. Natural substances are 
being increasingly tested for antimicrobial properties. An interesting 
study has shown that mammalian glutamate dehydrogenase could be 
inhibited by green tea phenolics [24]. Fermented lingonberry juice also 
contains polyphenols, and further studies are needed to establish the 
inhibitory factor(s) from lingonberry. Recently, a clinical pilot study 
revealed the reduction of oral fluid aMMP-8 in the oral cavity by a 
lingonberry oral mouthwash intervention and management [25]. 
The gelatinolytic activity and activation of human proMMP-8 by C. 
glabrata cell wall associated moonlighting proteases may be directly 
involved in the local connective tissue breakdown as well as induction 
and modulation of the inflammatory immune responses in the affected 
tissues by the invading yeast. Inhibition of this activity by fermented 
lingonberry juice in vitro may have clinical implications in C. glabrata 
infection control. The anti-inflammatory properties of fermented ling-
onberry juice are to be further investigated. 
4. Materials and methods 
4.1. Preparation of the C. glabrata cell wall fractions 
C. glabrata T-1638 was is a blood isolate from a Helsinki University 
Hospital patient. By preliminary gelatin-zymographic scanning of 
several blood isolates T-1638 showed highest gelatinolytic enzymatic 
activity. The cell wall extract was prepared by the following methods. 
Candida cells were first grown on Sabouraud dextrose agar (Lab M, Bury, 
UK) 24 h at 37 ◦C, then in 4 l yeast (0.5%) peptone (1%) glucose (1%) 
(YPG) 24 h at 37 ◦C on a waterbath with shaking. After filtering (Mil-
lipore Express™ Plus; 0,22 μm; Merck, Darmstadt, Germany) the cells 
were washed and centrifuged (3095 g, 10 min, RT) twice with PBS 
(phosphate buffered saline). The cells were incubated with 30 U/ml 
lyticase (Sigma-Aldrich, St Louis, MO) for 22 h at 31 ◦C in PBS on gentle 
shaking and centrifuged (3095 g, RT). The supernatant was stored at 
− 20 ◦C and volume was restored with PBS. The cells were incubated a 
second time with lyticase similarly and the obtained supernatants were 
pooled (cell wall fraction). The cell wall fraction was centrifuged with 
10 kDa and 50 kDa cutoff filters according to the manufacturer’s in-
structions (Amicon® Ultra- 15, Millipore, Billerica, MA), fraction vol-
umes were restored with PBS and proteins were recovered from the filter 
to obtain 10–50 kDa and >50 kDa fractions. 
4.2. Gelatin-zymography 
To estimate gelatinolytic activity of the fractions, 8% MDPF (2- 
Fig. 1. SDS-PAGE of C. glabrata protease fractions with and without salt/ 
mercaptoethanol (ME) exposure. Lane 1. MW standards, 2. fraction before 
DEAE- Sephadex, 3. fraction before DEAE- Sephadex, ME-treated (1.5 mM), 4. 
fraction before DEAE- Sephadex, salt treated, 5. fraction before DEAE- 
Sephadex, salt and ME (1.5 mM) treated, 6.10–50 kDa fraction before DEAE. 
Fig. 2. Gelatin-zymography of DEAE- Sephadex/G-200 fractions of Candida 
glabrata protease purification with and without mercaptoethanol (ME). Lane 1. 
Mw standards, 2. Fraction 8 (DEAE+ 1,5 mM ME), 3. Fr 3 (DEAE + G-200 +
1,5 mM ME), 4. Fr 4 (DEAE + G-200 + 1,5 mM ME), 5. Fr 8 (DEAE, without 
ME), 6. Fr 3 (DEAE + G-200, without ME), 7. Fr 4 (DEAE + G-200, without ME). 
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methoxy-2,4-dephenyl-3 (2H) -furanone)- gelatin (1%) zymography was 
performed according to Pärnänen et al. [17]. The original cell wall 
extract and the >50 kDa fraction was treated also with 2 μl β-mercap-
toethanol (final concentration = 1.5 mM) at 37 ◦C for 1 h. A parallel 8% 
SDS- PAGE was run. 
4.3. Salt and mercaptoethanol (ME) treatments 
To estimate ionic or disulfide bonds in the enzyme, 100 μl of the >50 
kDa fraction was incubated in 1 ml 20 mM Tris-HCl, pH 8.2 + 0.5 M 
NaCl for 1 h, centrifuged with a Millipore 10–50 kDa cutoff device 
(3095 g, 10 min, RT) and washed twice. The flowthrough was also 
collected and concentrated 10 × with a Millipore 10 kDa cutoff device. 
Samples of the >50 kDa fraction and the salt-treated fractions were 
incubated with or without 2 μl of β-mercaptoethanol (final concentra-
tion = 1.5 mM) for 1 h (37 ◦C). Samples were run on 8% MDPF-gelatin 
zymography. 
4.4. Ion-exchange chromatography 
Tha buffer of the >50 kDa fraction was changed to 20 mM Tris-HCl, 
pH 8.2. Ion-exchange with diethylaminoethyl cellulose chromatography 
for the >50 kDa cell wall extract was performed according to the 
manufacturer’s instructions (DEAE- FF, HiTrap® IEX Selection kit, GE 
Healthcare, Chicago, IL). The proteases were eluted with 0.5 M NaCl in 
20 mM Tris-HCl, pH 8.2. 
4.5. Gel filtration 
A 15 cm column (V = 9.5 ml) was used for gel filtration. Sephadex G- 
100 filtration for both 10–50 kDa and >50 kDa fractions, and Sephadex 
G-200 filtration for the >50 kDa fraction were performed. 
Inhibition of gelatinolytic enzymatic activities were tested with 2 μl 
β-mercaptoethanol (final concentration = 1.5 mM) (incubated 2 h, 
37 ◦C). 
Parallel 8% SDS-PAGE with silver stain were run. 
4.6. ProMMP-8 conversion and inhibition assays 
10–50 kDa and >50 kDa isolated candidal protease fractions were 
tested for the ability to convert and fragment the full-size 70–75 kDa 
human proMMP-8.5 μl of the fractions were incubated with 0.8 μg of 
70–75 kDa proMMP-8 (R&D System, Oxon, UK) for 0, 1, 2, 5 h, o/n at 
37 ◦C. As positive control, proMMP-8 was treated and activated by 1 mM 
aminophenylmercuric acetate (APMA) used as described by Nieminen 
et al. [12]. Inhibition of the activity was performed with the same 
timeframe using locally produced fermented lingonberry juice, final 
concentration 5 μg/μl (Lingora®; 0,1 μg/μl; Vantaa, Finland [25,26]). 
4.7. Western immunoblot 
The detection of proMMP-8 conversion and inhibition was verified 
by a modified enhanced chemiluminesence (ECL) Western blotting kit 
according to the protocol recommended by the manufacturer (GE 
Healthcare, Buckinghamshire, UK). As specific primary and secondary 
antibodies were performed polyclonal anti- MMP-8 [27] and anti-rabbit 
IgG horseradish peroxidase-linked (GE Healthcare, Buckinghamshire, 
UK), respectively [12,28]. 
4.8. Mass analysis 
Parallel 8% SDS-PAGE gels were silver-stained [29], protein bands 
Fig. 3. Silver stained 8% SDS-PAGE analyses of fractions sequenced. Fig. 3a. 1: Met 6 (85.9 kDa); 2. GDH (49.7 kDa); 3. PGK (44.6 kDa); Fig. 3b. 4: GPI (61.3 kDa); 3. 
GDH (49.7 kDa); 5. transaldolase (36.7 kDa). 
Fig. 4. Western immunoblot analysis of the effects of 
>50 kDa Candida glabrata protease fraction with and 
without Lingora® on purified latent 75 kDa human 
proMMP-8. Incubation times indicated. Fig. 4a: Lane 
1. proMMP-8; 2. proMMP-8+ > 50 kDa fraction, 30 
min; 3. proMMP-8+ > 50 kDa fraction, 1 h; 4. 
proMMP-8+ > 50 kDa fraction, 2 h; 5. proMMP-8+ >
50 kDa fraction, 5 h; 6. proMMP-8+ APMA, 1 h. 
Fig. 4b: Lane 1. proMMP-8; 2. proMMP-8+ 5 μl Lin-
gora®, 30 min; 3. proMMP-8 + > 50 kDa fraction, 30 
min; 4. proMMP-8 + > 50 kDa fraction + Lingora®, 
30 min; 5. proMMP-8+ >50 kDa fraction + Lingora®, 
1 h; 6.proMMP-8 + > 50 kDa fraction + Lingora®, 2 
h; 7. proMMP-8 + > 50 kDa fraction + Lingora®, 5 h. 
Mobilities of the molecular weight standards are 
indicated on the left.   
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were cut out of the polyacrylamide gel and “in-gel” digested. Cystein 
bonds were reduced with 0.045 M dithiothreitol (#D0632 
Sigma-Aldrich, St. Louis, MO) for 20 min at 37 ◦C and alkylated with 0.1 
M iodoacetamide (#57670 Sigma-Aldrich, St. Louis, MO) at room tem-
perature. Samples were digested by adding 0.75 μg trypsin (Sequencing 
Grade Modified Trypsin, V5111, Promega) for overnight at 37 ◦C. After 
digestion peptides were purified with C18 microspin columns (Harvard 
Apparatus, Holliston, MA) and the dried peptides were reconstituted in 
30 μl of buffer A [0.1% trifluoroacetic acid (TFA) in 1% acetonitrile]. 
Mass analysis was performed as in El Omar et al. [30], but with a 6 μl 
sample size. Liquid chromatography coupled to tandem mass spec-
trometry (LC-MS/MS) analysis was carried out on an EASY-nLC1000 
(Thermo Fisher Scientific, Darmstadt, Germany) connected to a Velos 
Pro-Orbitrap Elite hybrid mass spectrometer (Thermo Fisher Scientific, 
Germany) with nano electrospray ion source (Thermo Fisher Scientific, 
Germany). The LC-MS/MS samples were separated using a two-column 
setup consisting of a 2 cm C18-Pepmap trap column (Thermo Fisher 
Scientific, Germany), followed by 15 cm C18-Pepmap analytical column 
(Thermo Fisher Scientific, Germany). The linear separation gradient 
consisted of 5% buffer B in 5 min, 35% buffer B in 60 min, 80% buffer B 
in 5 min and 100% buffer B in 10 min at a flow rate of 0.3 μl/min (buffer 
A: 0.1% TFA in 1% acetonitrile; buffer B: 0.1% TFA acid in 98% 
acetonitrile). 6 μl of sample was injected per LC-MS/MS run and 
analyzed. Full MS scan was acquired with a resolution of 60 000 at 
normal mass range in the orbitrap analyzer and followed with CID –MS2 
top 20 most intense precursor ions within ion trap (energy 35). Data was 
acquired using LTQ Tune software. 
Acquired MS2 scans were searched against Uniprot Candida glabrata 
protein database using the Sequest search algorithms in Thermo Prote-
ome Discoverer. Allowed mass error for the precursor ions was 15 ppm 
and for the fragment 0.8 Da. A static residue modification parameter was 
set for carbamidomethyl +57.021 Da (C) of cysteine residue. Methio-
nine oxidation was set as dynamic modification +15.995 Da (M). Only 
full-tryptic peptides were allowed for maximum of 1 missed cleavages 
were considered. 
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M. Laaksonen, L. Laakkonen, J. Finne, T.K. Korhonen, Glutamine synthetase and 
glucose-6-phosphate isomerase are adhesive moonlighting proteins of Lactobacillus 
crispatus released by epithelial cathelicidin LL-37, J. Bacteriol. 194 (2012) 
2509–2519, https://doi.org/10.1128/JB.06704-11. 
[7] B.J. Giardina, B.A. Stanley, H.L. Chiang, Glucose induces rapid changes in the 
secretome of Saccharomyces cerevisiae, Proteome Sci. 12 (2014) 9, https://doi.org/ 
10.1186/1477-5956-12-9. 
[8] J. Karkowska-Kuleta, A. Kozik, Cell wall proteome of pathogenic fungi, Acta 
Biochim. Pol. 62 (2015) 339–351, https://doi.org/10.18388/abp. 
[9] C.J. Jeffery, Moonlighting proteins, Trends Biochem. Sci. 24 (1999) 8–11, https:// 
doi.org/10.1016/s0968-0004(98)01335-8. 
[10] M.L. Delgado, J.E. O’Connor, I. Azorín, J. Renau-Piqueras, M.L. Gil, D. Gozalbo, 
The glyceraldehyde-3-phosphate dehydrogenase polypeptides encoded by the 
Saccharomyces cerevisiae TDH1, TDH2 and TDH3 genes are also cell wall proteins, 
Microbiol-UK 147 (2001) 411–417. 
[11] T. Sorsa, T. Ingman, K. Suomalainen, M. Haapasalo, Y. Konttinen, O. Lindy, 
H. Saari, V.-J. Uitto, Identification of proteases from periodontopathogenic 
bacteria as activators of latent human neutrophil and fibroblast- type interstitial 
collagenases, Infect. Immun. (1992) 4491–4495, https://doi.org/10.1128/ 
iai.60.11.4491-4495.1992. 
[12] M.T. Nieminen, D. Listyarifah, J. Hagström, C. Haglund, D. Grenier, D. Nordström, 
V.-J. Uitto, M. Hernandez, T. Yucel-Lindberg, T. Tervahartiala, M. Ainola, T. Sorsa, 
Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive 
carcinogenesis through immunomodulation, Br. J. Canc. 118 (2018) 428–434, 
https://doi.org/10.1038/bjc.2017.409. 
[13] T. Okamoto, T. Akaike, M. Suga, S. Tanase, H. Horie, S. Miyajima, M. Ando, 
Y. Ichinose, H. Maeda, Activation of human matrix metalloproteinases by various 
bacterial proteinases, J. Biol. Chem. 272 (1997) 6059–6066, https://doi.org/ 
10.1074/jbc.272.9.6059. 
[14] K. Hockensmith, K. Dillard, B.A. Harville, Identification and characterization of a 
chymotrypsin-like serine protease from periodontal pathogen, Tannerella forsythia, 
Microb. Pathog. 100 (2016) 37–42, https://doi.org/10.1016/j. 
micpath.2016.08.041. 
[15] I. Claveau, Y. Mostefaoui, M. Rouabhia, Basement membrane protein and matrix 
metalloproteinase deregulation in engineered human oral mucosa following 
infection with Candida albicans, Matrix Biol. 23 (2004) 477–486, https://doi.org/ 
10.1016/j.matbio.2004.08.006. 
[16] M.H. Rodier, B. El Moudni, C. Kauffmann-Lacroix, J.L. Daniault, J.-L. Jaquemin, 
A Candida albicans metallopeptidase degrades constitutive proteins of extracellular 
matrix, FEMS Microbiol. Lett. 177 (1999) 205–210, https://doi.org/10.1111/ 
j.1574-6968.1999.tb13733.x. 
[17] P. Pärnänen, K. Kari, I. Virtanen, T. Sorsa, J.H. Meurman, Human laminin-332 
degradation by Candida proteinases, J. Oral Pathol. Med. 37 (2008) 329–335, 
https://doi.org/10.1111/j.1600-0714.2008.00638. 
[18] P. Pärnänen, J. Meurman, I. Virtanen, Laminin- 511 and fibronectin degradation 
with Candida yeast, J. Oral Pathol. Med. 38 (2009) 768–772, https://doi.org/ 
10.1111/j.1600-0714.2009.00785.x. 
[19] P. Pärnänen, J. Meurman, L. Samaranayake, I. Virtanen, Human oral keratinocyte 
E- cadherin degradation by Candida albicans and Candida glabrata, J. Oral Pathol. 
Med. 39 (2010) 275–278, https://doi.org/10.1111/j.1600-0714.2009.00866.x. 
[20] P. Pärnänen, J. Meurman, T. Sorsa, The effects of Candida proteinases on human 
proMMP-9, TIMP-1 and TIMP-2, Mycoses 54 (2010) 325–330, https://doi.org/ 
10.1111/j.1439-0507.2010.01889.x. 
[21] J. Karkowska-Kuleta, D. Satala, O. Bochenska, M. Rapala-Kozik, A. Kozik, 
Moonlighting proteins are variably exposed at the cell surfaces of Candida glabrata, 
Candida parapsilosis and Candida tropicalis under certain growth conditions, BMC 
Microbiol. 19 (2019) 149, https://doi.org/10.1186/s12866-019-1524-5. 
[22] M.L. Gil, M.L. Delgado, D. Gozalbo, The Candida albicans cell wall-associated 
glyceraldehyde-3-phosphate dehydrogenase activity increases in response to 
starvation and temperature upshift, Med. Mycol. 39 (2001) 387–394. 
[23] C.R. Halsey, S. Lei, J.K. Wax, M.K. Lehman, A.S. Nuxol, L. Steinke, M. Sadykov, 
R. Powers, P.D. Fey, Amino acid catabolism in Staphylococcus aureus and the 
function of carbon catabolite repression, mBio 8 (2017), https://doi.org/10.1128/ 
mBio.01434-16. 
P. Pärnänen et al.                                                                                                                                                                                                                               
Microbial Pathogenesis 149 (2020) 104547
5
[24] M. Li, C.J. Smith, M.T. Walker, T.J. Smith, Novel inhibitors complexed with 
glutamate dehydrogenase: allosteric regulation by control of protein dynamics, 
J. Biol. Chem. 284 (2009) 22988–23000, https://doi.org/10.1074/jbc. 
M109.020222. 
[25] P. Pärnänen, P. Nikula-Ijäs, T. Sorsa, Antimicrobial and anti-inflammatory 
lingonberry mouthwash- a clinical pilot study in the oral cavity, Microorganisms 7 
(2019) 331, https://doi.org/10.3390/microorganisms7090331. 
[26] P. Pärnänen, A preparation for balancing the composition of the oral microbial 
flora, Europatent (2017), 2 585 087 B1. 
[27] R. Hanemaaijer, T. Sorsa, Y.T. Konttinen, Y. Ding, M. Sutinen, H. Visser, V.W. 
M. van Hinsbergh, T. Helaakoski, T. Kainulainen, J. Virkkunen, H. Tschesche, 
T. Salo, Matrix metalloproteinase- 8 is expressed in rheumatoid synovial fibroblast 
and endothelial cells. Regulation by TNF-α and doxycycline, J. Biol. Chem. 272 
(1997) 31054–31509, https://doi.org/10.1074/jbc.272.50.31504. 
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